1) Welcome to this CE/#CME-accredited #tweetorial: “Use of JAK Inhibitors in AD: The Allergist’s Perspective.” I’m your author, Juan C. Ivancevich (@Aller_MD) from Universidad del Salvador, Buenos Aires, Argentina 🇦🇷. Join us, FOLLOW US, and earn 0.5h 🆓CE/#CME credit! pic.twitter.com/aiPuZh8kCg — @derm_ce (@derm_ce) May 23, 2022
May 23, 2022
Use of JAK Inhibitors in AD: The Allergist’s Perspective.Tweetorial. CME
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment